학술논문

Optimum adjuvant trastuzumab duration for human epidermal growth factor receptor-2 positive breast cancer: a network meta-analysis of randomized trials
Document Type
Journal
Source
TRANSLATIONAL CANCER RESEARCH; APR 2021, 10 4, p1628-p+, 22p.
Subject
Language
English
ISSN
22196803